News
Feed
Events
Feed
News
+ Events
Feed

Novavax, Inc.

  • ISIN US6700021040

Aktuelle News

30 April 2015

22:05 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 7, 2015

8 April 2015

22:01 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax to Present at the 14th Annual Needham Healthcare Conference

31 März 2015

22:01 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Announces Closing of Public Offering

28 März 2015

14:00 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Presents New Data From Non-Human Primate Ebola Challenge at the 7th International Symposium on Filoviruses

26 März 2015

13:00 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Prices Public Offering of Common Stock

24 März 2015

21:02 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Announces Proposed Public Offering of Common Stock

10 März 2015

21:10 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Appoints Brian Rosen as Vice President, Government Affairs

26 Februar 2015

22:26 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Reports Fourth Quarter and Year-End 2014 Financial Results

19 Februar 2015

22:05 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015

12 Februar 2015

14:30 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Announces Initiation of Ebola Vaccine Phase 1 Clinical Trial Supported by Non-Human Primate Challenge Data and Documented Rapid Manufacturing Capabilities

8 Januar 2015

22:05 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Announces Management Promotion

7 Januar 2015

16:15 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax to Present at the 33rd Annual J.P. Morgan Healthcare Conference

26 November 2014

14:30 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax to Present at the 26th Annual Piper Jaffray Healthcare Conference

20 November 2014

14:30 Corporate EN

Novavax, Inc.

Corporate
EN

U.S. FDA Grants Fast Track Designation to Novavax’ RSV F-Protein Nanoparticle Vaccine for Protection of Infants Via Maternal Immunization

17 November 2014

22:05 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Initiates Phase 2 Clinical Trial of Quadrivalent Seasonal Influenza VLP

13 November 2014

15:30 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax to Present at the Jefferies Global Healthcare Conference

10 November 2014

14:30 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Initiates Phase 1 Clinical Trial of RSV F Vaccine in Pediatric Subjects

6 November 2014

23:31 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax and Collaborators Make Multiple Presentations at the 9th International Respiratory Syncytial Virus Symposium in South Africa, November 9-13, 2014

5 November 2014

22:24 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Reports Third Quarter 2014 Financial Results

30 Oktober 2014

13:30 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax to Host Conference Call to Discuss Third Quarter 2014 Financial Results on November 5, 2014

29 Oktober 2014

22:28 Corporate EN

Novavax, Inc.

Corporate
EN

U.S. FDA Grants Fast Track Designation to Novavax’ H7N9 Influenza Virus-Like Particle Vaccine Candidate Adjuvanted With Matrix-M(TM)

27 Oktober 2014

12:30 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Announces Ebola Vaccine Development Program at the 8th Vaccine and ISV Conference in Philadelphia

26 Oktober 2014

15:04 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Presents RSV F Protein Nanoparticle Vaccine Clinical Data at the 8th Vaccine & ISV Congress in Philadelphia on Sunday, October 26

23 Oktober 2014

22:20 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax to Present RSV Vaccine Clinical Data at the 8th Vaccine & ISV Congress in Philadelphia on Sunday, October 26

15 Oktober 2014

14:30 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Study Published in Vaccine: RSV F-Protein Nanoparticle Vaccine Induces Antigenic Site II Antibodies

14 Oktober 2014

14:30 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Initiates Phase 2 Clinical Trial of RSV Vaccine in Elderly Subjects

23 September 2014

14:45 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Announces BARDA Exercise of Contract Option

14:30 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax’ H7N9 Avian Influenza VLP Vaccine Candidate With Matrix-M(TM) Delivers Positive Phase 1/2 Clinical Data

16 September 2014

22:05 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy Third-Trimester Pregnant Women

22:04 Corporate EN

Novavax, Inc.

Corporate
EN

Novavax Initiates Phase 2 Clinical Trial of RSV F-Protein Nanoparticle Vaccine Candidate in Healthy Third-Trimester Pregnant Women

Anstehende Events

Keine Events gefunden